Insider Trading disclosures for Decibel Therapeutics Inc

The latest disclosure was made by Laurence E. Reid in Decibel Therapeutics Inc where a trade of 72,000 Stock Options (right to buy) done was reported to US exchanges on March 16, 2023.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Laurence E. Reid Director, See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Mar 2023 72,000 72,000 - - Stock Options (right to buy)
Laurence E. Reid Director, See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Mar 2023 195,000 220,849 - 0 Common Stock
Anna Trask Chief People Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jan 2023 45,000 45,000 - - Stock Options (right to buy)
Anna Trask Chief People Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jan 2023 105,000 106,864 - 0 Common Stock
John Lee Chief Development Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jan 2023 45,000 45,000 - - Stock Options (right to buy)
John Lee Chief Development Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jan 2023 120,000 147,144 - 0 Common Stock
Peter A. Thompson Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2022 10,000 10,000 - - Stock Option (right to buy)
Neil Exter Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2022 10,000 10,000 - - Stock Option (right to buy)
Alison Cecily Finger Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2022 10,000 10,000 - - Stock Option (right to buy)
William H. Carson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2022 10,000 10,000 - - Stock Option (right to buy)
Saraswathy V. Nochur Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2022 10,000 10,000 - - Stock Option (right to buy)
John Lee Chief Development Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Feb 2022 52,500 52,500 - - Stock Options (right to buy)
Laurence E. Reid Director, See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Feb 2022 187,500 187,500 - - Stock Options (right to buy)
Elisabeth Leiderman Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Feb 2022 52,500 52,500 - - Stock Options (right to buy)
Anna Trask See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Feb 2022 52,500 52,500 - - Stock Options (right to buy)
Anna Trask See Remarks Sale of securities on an exchange or to another person at price $ 5.00 per share. 03 Jan 2022 1 2,241 - 5 5 Common Stock
Anna Trask See Remarks Sale of securities on an exchange or to another person at price $ 5.03 per share. 03 Jan 2022 377 1,864 - 5.0 1,896 Common Stock
Anna Trask See Remarks Sale of securities on an exchange or to another person at price $ 6.34 per share. 02 Dec 2021 378 2,242 - 6.3 2,395 Common Stock
Anna Trask See Remarks Sale of securities on an exchange or to another person at price $ 6.37 per share. 02 Dec 2021 4,913 2,620 - 6.4 31,293 Common Stock
Anna Trask See Remarks Sale of securities on an exchange or to another person at price $ 8.34 per share. 03 Nov 2021 378 7,533 - 8.3 3,152 Common Stock
Anna Trask SEE REMARKS Sale of securities on an exchange or to another person at price $ 8.31 per share. 02 Nov 2021 4,913 7,911 - 8.3 40,827 Common Stock
Anna Trask See Remarks Sale of securities on an exchange or to another person at price $ 7.55 per share. 14 Oct 2021 5,364 12,824 - 7.5 40,481 Common Stock
William H. Carson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Jun 2021 20,000 20,000 - - Stock Option (right to buy)
Neil Exter Director, Ten Percent Owner 17 Feb 2021 289,603 0 - - Series D Preferred Stock
Peter A. Thompson Director, Ten Percent Owner 17 Feb 2021 218,568 218,568 - - Common Stock
Peter A. Thompson Director, Ten Percent Owner 17 Feb 2021 2,732,106 2,732,106 - - Common Stock
Peter A. Thompson Director, Ten Percent Owner 17 Feb 2021 327,852 327,852 - - Common Stock
Peter A. Thompson Director, Ten Percent Owner 17 Feb 2021 1,158,412 0 - - Series D Preferred Stock
Peter A. Thompson Director, Ten Percent Owner 17 Feb 2021 1,737,619 0 - - Series D Preferred Stock
Peter A. Thompson Director, Ten Percent Owner 17 Feb 2021 14,480,162 0 - - Series D Preferred Stock
Peter A. Thompson Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 18.00 per share. 17 Feb 2021 555,566 883,418 - 18 10,000,188 Common Stock
Peter A. Thompson Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 18.00 per share. 17 Feb 2021 1,111,100 3,843,206 - 18 19,999,800 Common Stock
Neil Exter Director, Ten Percent Owner 17 Feb 2021 98,929 3,085,043 - - Common Stock
Neil Exter Director, Ten Percent Owner 17 Feb 2021 54,642 3,139,685 - - Common Stock
Neil Exter Director, Ten Percent Owner 17 Feb 2021 1,250,000 0 - - Series C Preferred Stock
Neil Exter Director, Ten Percent Owner 17 Feb 2021 45,638,882 0 - - Series A Preferred Stock
Matthew Foy Director, Ten Percent Owner 17 Feb 2021 3,125,000 0 - - Series C Preferred Stock
Matthew Foy Director, Ten Percent Owner 17 Feb 2021 7,119,852 0 - - Series A Preferred Stock
Matthew Foy Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 18.00 per share. 17 Feb 2021 150,000 1,183,663 - 18 2,700,000 Common Stock
Matthew Foy Director, Ten Percent Owner 17 Feb 2021 327,852 1,033,663 - - Common Stock
Matthew Foy Director, Ten Percent Owner 17 Feb 2021 247,324 705,811 - - Common Stock
Matthew Foy Director, Ten Percent Owner 17 Feb 2021 458,487 458,487 - - Common Stock
Matthew Foy Director, Ten Percent Owner 17 Feb 2021 1,737,619 0 - - Series D Preferred Stock
Neil Exter Director, Ten Percent Owner 17 Feb 2021 2,938,945 2,986,114 - - Common Stock
Matthew Foy Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Feb 2021 20,000 20,000 - - Stock Option (right to buy)
Neil Exter Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Feb 2021 20,000 20,000 - - Stock Option(right to buy)
Christine A. Poon Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Feb 2021 20,000 20,000 - - Stock Option (right to buy)
Peter A. Thompson Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Feb 2021 20,000 20,000 - - Stock Option (right to buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures